Patent Issued for Capsid inhibitors for the treatment of HIV (USPTO 11944611).

This document is a patent for a method of treating HIV infection using a pharmaceutical composition. The composition includes a sodium salt compound and other compounds such as HIV protease inhibitors and reverse transcriptase inhibitors. The method is intended for heavily treatment-experienced patients with HIV-1 mutant resistance to antiretroviral medications. The composition can be administered in the form of a tablet with specific percentages of each ingredient. The patent provides detailed information on the formulation and dosage of the composition. [Extracted from the article]